NASHVILLE, Tenn. (WTVF) — The Food and Drug Administration (FDA) announced it will remove black box warning labels from many hormone replacement therapy medications, a change that could help generations of women manage menopause symptoms more effectively.

The warning labels, which have been in place for more than 20 years, cautioned about cancer risks associated with hormone therapy.

However, some medical professionals believe the research that prompted these warnings didn't accurately represent health risks for most women.

"It was a study that skewed the results to older, more unhealthy women," said Lisa Milam, a nurse practitioner with Ascension Saint Thomas' Menopause Wellness Center.

Milam called the FDA's decision a significant moment for women's health.

"It's just a wonderful mo

See Full Page